BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 9708799)

  • 1. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.
    Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM
    Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-B promotes in vivo angiogenesis.
    Silvestre JS; Tamarat R; Ebrahimian TG; Le-Roux A; Clergue M; Emmanuel F; Duriez M; Schwartz B; Branellec D; Lévy BI
    Circ Res; 2003 Jul; 93(2):114-23. PubMed ID: 12805240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia.
    Takeshita S; Pu LQ; Stein LA; Sniderman AD; Bunting S; Ferrara N; Isner JM; Symes JF
    Circulation; 1994 Nov; 90(5 Pt 2):II228-34. PubMed ID: 7525111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
    Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
    Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
    FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia.
    Hopkins SP; Bulgrin JP; Sims RL; Bowman B; Donovan DL; Schmidt SP
    J Vasc Surg; 1998 May; 27(5):886-94; discussion 895. PubMed ID: 9620141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor C induces angiogenesis in vivo.
    Cao Y; Linden P; Farnebo J; Cao R; Eriksson A; Kumar V; Qi JH; Claesson-Welsh L; Alitalo K
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14389-94. PubMed ID: 9826710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia.
    Shyu KG; Chang H; Isner JM
    Life Sci; 2003 Jun; 73(5):563-79. PubMed ID: 12770612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
    Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
    Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3.
    Mäkinen T; Veikkola T; Mustjoki S; Karpanen T; Catimel B; Nice EC; Wise L; Mercer A; Kowalski H; Kerjaschki D; Stacker SA; Achen MG; Alitalo K
    EMBO J; 2001 Sep; 20(17):4762-73. PubMed ID: 11532940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of coronary artery disease on expression and microvascular response to VEGF.
    Métais C; Li J; Li J; Simons M; Sellke FW
    Am J Physiol; 1998 Oct; 275(4):H1411-8. PubMed ID: 9746492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.
    Horowitz JR; Rivard A; van der Zee R; Hariawala M; Sheriff DD; Esakof DD; Chaudhry GM; Symes JF; Isner JM
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2793-800. PubMed ID: 9409257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.
    Fabre JE; Rivard A; Magner M; Silver M; Isner JM
    Circulation; 1999 Jun; 99(23):3043-9. PubMed ID: 10368123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent impairment of angiogenesis.
    Rivard A; Fabre JE; Silver M; Chen D; Murohara T; Kearney M; Magner M; Asahara T; Isner JM
    Circulation; 1999 Jan 5-12; 99(1):111-20. PubMed ID: 9884387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.